USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Patent Cliff and the Future of Generics in Asia
Patent Cliff and the Future of Generics in Asia
Trends that will Impact the Market in the Short Term
RELEASE DATE
19-Dec-2014
19-Dec-2014
REGION
Asia Pacific
Asia Pacific
Research Code: P860-01-00-00-00
SKU: LS00147-AP-MR_16988
$2,450.00
In stock
SKU
LS00147-AP-MR_16988
Description
The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a significant percentage of products to the US and Europe. India, China, South Korea, and Japan are the important Asian markets. The generics industry has moved on after patent cliff, and is more focused on increasing product quality and market share. Overall, the global generics market will see an average growth in the next 2-3 years.
Table of Contents
Executive Summary
Executive Summary (continued)
Executive Summary (continued)
Executive Summary (continued)
Executive Summary (continued)
Key Questions This Study Will Answer
Research Process and Methodology
What Will The Global Generics Market Look Like in 2015?
What Can We Expect in the Next Three Years?
Opportunities by Therapeutic Segments—Cardiovascular Disease Remains the Most Attractive Segment till 2018
Opportunities by Product Segments—Biologics or Oral Solids?
With Less Molecules To Lose Exclusivity, Will the Generics Industry Continue To Grow?
Major Losses Due To Patent Cliff in 2014
Selected Patent Expiries in 2015
Who Gets the Maximum Advantage Post Loss of Exclusivity (LOE) of Major Drugs?
Challenges for Drug Manufacturers
Major Models and Trends Post 2012 LOE
Activities in the Asian Generics Market
Major Approvals and New Products in Asia-Pacific Generics Market in 2014
Indian Generics Market
Indian Generics Market (continued)
Indian Market is Mix of Branded Generics and Un-branded Generics
Universal Health Coverage Scheme 2015–2019
Universal Health Coverage in India and its Implications
To Meet The Demands of Domestic Markets, Generic Manufacturers Have to Produce a Surplus
Markets Other than India to be Equally Lucrative for Generic Manufacturers
China
Chinese Generics Market in 2014
Generics Market Boom Likely in the Next 3 Years
Japan
LOE Scenario in Japanese Pharma Industry 2014–2015
Japanese Generics Market in 2014
Key Focus of Japanese Pharma Industry—“Quality”
The Philippines
Indonesia
Taiwan and Malaysia
Rest of Asia
India, Indonesia, Vietnam, and China to lead APAC
Strategies
First-mover Advantage: Case Study—Cymbalta
The Last Word
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a significant percentage of products to the US and Europe. India, China, South Korea, and Japan are the important Asian markets. The generics industry has moved on after patent cliff, and is more focused on increasing product quality and market share. Overall, the global generics market will see an average growth in the next 2-3 years.
| No Index | Yes |
|---|---|
| Podcast | No |
| Author | Siddharth Dutta |
| WIP Number | P860-01-00-00-00 |
| Is Prebook | No |